Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to ...

Sara H. Jodka of Dickinson Wright PLLC discusses the legal landscape surrounding GLP-1 programs for weight loss, in light of ...

A new European obesity framework adds waist-to-height ratio and comorbidities to BMI assessment. Could this help identify ...

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

This is but a fact that obesity drugs are only going to get more accessible for Indians post March 2026. But whether they ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

Obesity before pregnancy, not just during, may shape a child’s brain and raise the risk of autism spectrum disorder, a new ...

Childhood obesity is increasing globally with over 35 million children affected in 2024. Experts warn that early intervention ...

The COVID-19 pandemic drastically altered health care across the globe, with obesity management undergoing significant ...

This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" ...

For patients with inflammatory bowel disease and obesity, bariatric surgery is associated with improved inflammatory bowel ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk has completed a study titled A ...